9Magiakou MA, Manousaki D, Papadaki M, et al. The efficacy and safe- ty of gonadotrepin - releasing hormone analog treatment in childhood and adolescence : asingle center, long - term tbllow - up study [ J ]. J Clin Endocrinol Metab, 2010,95 ( 1 ) : 109 - 117.
2Salerno M, Di Maio S, Gasparini N, et al. Central precocious puberty: a single blood sample after gonadotrepin-releasing hormone agonist administration in monitoring treatment. Horm Res, 1998,50: 205-211.
3Pasquino AM, Pucarelli I, Segni M, et al. Adult height in girls with central precocious puterty treated with gonadotropin-releasing hormone analogues and growth hormone. J Clin Endocrinol Matab,1999,84:449-452.
4Pucarelli I, Segni M, Ortore M, et al. Combined therapy with GnRH analog plus growth hormone in central precocious puberty. J Pediatr Endocrinol Matab, 2000,13:811-820.
5Heger S, Joachim Partsch C, SippellWG. Long-term outcome after depot gonadotopin-releasing hormone agonist treatment of central precocious puberty: final height, body propor-tions, body composition, bone mineral density, and reproductive function [ J ]. J Clin Endocrinol Metab, 1999, 84: 4583.
6Walroord EC, Pescovitz OH . Combined use of growth hormone and gonadotropinreleasing hormone analogues in precocious puberty: Theoretics and practical considerations [J]. Pecliatrics, 1999, 104:1010 -1014.
7Kamp GA, Mul D, Waelkens, et al . A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation [ J ]. J Clin Endocrinol Metab, 2001,86:2969 - 2975.
